SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015623
Filing Date
2024-11-14
Accepted
2024-11-14 08:00:34
Documents
57
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sgmt-20240930x10q.htm   iXBRL 10-Q 1574369
2 EX-31.1 sgmt-20240930xex31d1.htm EX-31.1 12264
3 EX-31.2 sgmt-20240930xex31d2.htm EX-31.2 13232
4 EX-32.1 sgmt-20240930xex32d1.htm EX-32.1 9879
  Complete submission text file 0001558370-24-015623.txt   6364589

Data Files

Seq Description Document Type Size
5 EX-101.SCH sgmt-20240930.xsd EX-101.SCH 30724
6 EX-101.CAL sgmt-20240930_cal.xml EX-101.CAL 31668
7 EX-101.DEF sgmt-20240930_def.xml EX-101.DEF 195388
8 EX-101.LAB sgmt-20240930_lab.xml EX-101.LAB 345701
9 EX-101.PRE sgmt-20240930_pre.xml EX-101.PRE 274313
60 EXTRACTED XBRL INSTANCE DOCUMENT sgmt-20240930x10q_htm.xml XML 1159590
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Filer) CIK: 0001400118 (see all company filings)

IRS No.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41742 | Film No.: 241457288
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)